Related Experiment Videos
Depot fluspirilene for schizophrenia
A Abhijnhan1, C E Adams, A David
1Cochrane Schizophrenia Group, Academic unit of Psychiatry and Behavioural Sciences, 15 Hyde Terrace, Leeds, UK, LS2 9LT. akhil.abith@gmail.com
The Cochrane Database of Systematic Reviews
|January 27, 2007
Summary
Depot fluspirilene shows no clear advantage over oral antipsychotics or other depot preparations for schizophrenia treatment. More research is needed to determine its benefits and inform clinical practice.
Area of Science:
- Psychiatry
- Clinical Pharmacology
- Evidence-Based Medicine
Background:
- Antipsychotic medications are standard treatment for schizophrenia.
- Long-acting depot injections, like fluspirilene, are used for maintenance therapy.
Purpose of the Study:
- To review clinical, social, and economic outcomes of depot fluspirilene compared to placebo, oral antipsychotics, and other depot antipsychotics in schizophrenia patients.
Main Methods:
- Systematic review of randomized controlled trials (RCTs) identified through the Cochrane Schizophrenia Group's Register.
- Included trials compared depot fluspirilene against placebo, oral antipsychotics, or other depot preparations.
- Outcomes assessed included mortality, global function, mental state, relapse, hospitalization, adverse effects, and treatment acceptability.
Main Results:
- Limited data showed no significant differences in global improvement or relapse rates between depot fluspirilene and oral or other depot antipsychotics.
- Extrapyramidal adverse effects were less common with fluspirilene (RR 0.50, NNH 5).
- No studies reported on hospital/service outcomes, patient satisfaction, or economic impact.
Conclusions:
- Small participant numbers in comparisons limit definitive conclusions.
- Current trial data do not clearly indicate advantages of fluspirilene over other treatments.
- Further high-quality randomized trials are necessary to guide clinical decisions regarding depot fluspirilene.
Related Concept Videos
01:21Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
01:17Schizophrenia
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those diagnosed.
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...